Karl B. Scheidweiler

Oxytocin by intranasal and intravenous routes reaches the cerebrospinal fluid in rhesus macaques: determination using a novel oxytocin assay

M R Lee, Karl B. Scheidweiler, Xingxing Diao et al. · Molecular Psychiatry · 2017 · 241 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +7

Free and Glucuronide Whole Blood Cannabinoids' Pharmacokinetics after Controlled Smoked, Vaporized, and Oral Cannabis Administration in Frequent and Occasional Cannabis Users: Identification of Recent Cannabis Intake

Matthew N. Newmeyer, Madeleine J. Swortwood, Allan J. Barnes et al. · Clinical Chemistry · 2016 · 178 citations

Pharmacy, Pharmacokinetics, Pharmacology +11

Impact of Prolonged Cannabinoid Excretion in Chronic Daily Cannabis Smokers' Blood on Per Se Drugged Driving Laws

Mateus M. Bergamaschi, Erin L Karschner, Robert S. Goodwin et al. · Clinical Chemistry · 2013 · 152 citations · Full text

Pharmacy, Pharmacology, Toxicology +16

Phase I and II Cannabinoid Disposition in Blood and Plasma of Occasional and Frequent Smokers Following Controlled Smoked Cannabis

Nathalie A. Desrosiers, Sarah K. Himes, Karl B. Scheidweiler et al. · Clinical Chemistry · 2014 · 150 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +7

Nontargeted SWATH acquisition for identifying 47 synthetic cannabinoid metabolites in human urine by liquid chromatography-high-resolution tandem mass spectrometry

Karl B. Scheidweiler, Michael J. Y. Jarvis, Marilyn A. Huestis · Analytical and Bioanalytical Chemistry · 2014 · 134 citations

Pharmacy, Pharmacology, Toxicology +17